Nutex
Missing: Nutex's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Nutex's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Nutex News
Dec 30, 2022
The shares of Nutex Health (NUTX) recently received a $3 price target. These are the details. The shares of Nutex Health (NUTX) recently received a $3 price target. Price target: $3 Analyst firm: Benchmark Benchmark analysts adjusted the rating while pointing out that the company became public on April 1 through the reverse merger of Nutex Health Holdco into publicly-held Clinigence Holdings. Plus, the company’s Hospital division – which generates about 88% of revenue – operates one of the country’s largest networks of micro-hospitals with 21 facilities, and the Population Health Management division Clinigence owns/operates provider networks supported by a SaaS-based data analytics capability. Plus, Nutex is growing quickly with a plan to nearly double the facility footprint in between 2023 and 2024. And even though the 2022 results were negatively impacted by the “No Surprises Act” implementation, it now is effectively negotiating improved rates. Trending on Pulse 2.0
Nutex Frequently Asked Questions (FAQ)
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.